IL4 and breast carcinoma: Anti-inflammatory cytokines such as IL-4, IL-13, and TGF-β may polarize macrophages into M2 phenotypes which are considered immunosuppressive and can contribute to breast cancer progression by promoting growth, metastasis, and angiogenesis.